Back to my company list

New
C

ConsoneAI

The AI engine Fit Assessment

Beta

The company delivers pharma-tech software for drug development, leveraging AI-based toxicity prediction (DioScor) to accelerate development, reduce costs and animal testing, and support regulatory IND submissions across preclinical to clinical stages.

Blurb

Operator of a disruptive technology intended for targeting the decisions that are made in the drug development process. The company offers a tool that helps accelerate the process of drug development, reduces the cost and time taken to get the medicines to market, allows medicines to be tested using software, removes the need for unnecessary environmental impacts, enabling businesses to predict toxicological effects and the viability of new drugs.

HQ Location

Wetherby (United Kingdom)

Founded

2020

Employees

1 - 10

Total funding raised

Not available

Funding Status

Not available

Operator of a disruptive technology intended for targeting the decisions that are made in the drug development process. The company offers a tool that helps accelerate the process of drug development, reduces the cost and time taken to get the medicines to market, allows medicines to be tested using software, removes the need for unnecessary environmental impacts, enabling businesses to predict toxicological effects and the viability of new drugs.